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ALTERING TEMPERATUREINA
MAMMALIAN BODY
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application claims the benefit of U.S. Provisional
Patent Application No. 61/276,764, filed Sep. 16, 2009 and
US. Provisional Patent Application No. 61/276,787, filed
Sep. 16, 2009, both of which are incorporated herein by
reference in their entirety.
TECHNICAL FIELD
The presentapplication relates to systems and methods for
altering temperature in a mammalian body. Optionally, the
systems and methodscan be used to loweror raise core body
temperature ofamammalian subject. Optionally, the systems
and methods can be used to loweror raise the temperature of
glabrous skin of a mammalian subject.
BACKGROUND
The thermoregulatory system of homeotherms has an
inherent ability to hold core body temperature within a small
variation of a set point. Excursions, above and below the set
point can cause compromised bodyfunction, injury, and even
death may occur.
Operation of the thermoregulatory system is based on a
complex, nonlinear network of feedback control signals and
responses to adjust the thermalresistance between the body
core and the environment and to modulate the rate and distri-
bution of internal energy generation. The operation of this
system is remarkably efficient over a broad spectrum of
physiological states and environmental conditions.
In certain circumstances, however, the thermoregulatory
system is unable to maintain the core temperature within the
set operational range, or there may be therapeutic or prophy-
lactic reasons to override the system to cause changesin the
core temperature beyond the normal range. There are also
situations whereitmay be desirable to alter the temperature of
portions ofthe body other than the body’s core. For example,
it may be desirableto alter the temperature ofglabrous skin in
a subject.
SUMMARY
The presentapplication relates to systems and methods for
altering temperature in a mammalian body. Optionally, the
systems and methodscan be used to loweror raise core body
temperature ofamammalian subject. Optionally, the systems
and methods can be used to loweror raise the temperature of
glabrous skin of a mammalian subject.
For example, provided are methodsfor increasing or main-
taining temperature of glabroustissue in a subject. Also pro-
vide are methods for cooling the core body temperature of a
subject. Further provided are methods for warming the core
body temperature of a subject.
The methods include applying heat to peripheral ther-
moregulatory control tissue of the subject. The applied heat
increases or maintains perfusion of blood in the glabrous
tissue. By increasing or maintaining perfusion, the tempera-
ture of the glabrous tissue can be optionally increased. In
someaspects, cooling stimulus can be applied to the glabrous
tissue with the increased or maintained perfusion. In other
aspects, a warming stimulus can be applied the glabrous
tissue with the increased or maintained perfusion. When a
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cooling stimulus is used, the core temperature of the subject
can be reduced. When a warming stimulus is used, the core
temperate of the subject can be increased.
Optionally, the peripheral thermoregulatory control tissue
is locatedin the cervical spinal region or in the lumbarspinal
region ofthe subject. Negative pressure can also be applied to
the glabrous tissue. The negative pressure can be used to
increase or maintain perfusion ofblood in the glabroustissue.
For the core cooling methods, the subject may have suf-
fered cardiopulmonary arrest, ischemic stroke, subarachnoid
hemorrhage, hepatic encephalopathy, trauma, brain surgery,
perinatal asphyxia, infantile encephalitis, a hyperthermic-in-
ducing event, or acute brain injury. With these conditions, the
methods can be usedto cool the core body temperature and to
establish hypothermia in the subject. For the warming meth-
ods, the subject may have suffered a hypothermia-inducing
event.
Also provided are systems for cooling the core body tem-
perature of a subject. The systems include a heating device
configured to apply heat to peripheral thermoregulatory con-
trol tissue of the subject. The applied heat increases or main-
tains perfusion of blood in the glabrous tissue. The systems
further comprise a cooling device configured to apply a cool-
ing stimulusto the glabrous tissue and may optionally com-
prise a device adapted to apply negative pressure to the gla-
broustissue.
The heating device can be adapted to deliver heat to the
cervical spinal region and/or lumbar spinal region of the
subject. Optionally, the heating device is configured to heat
the skin overlying the peripheral thermoregulatory control
tissue ofthe subject. Optionally, the heating device is config-
ured to heatthe tissue below the skin overlying the peripheral
thermoregulatory control tissue of the subject. The heating
device canbe optionally selected from the group consisting of
a resistive heating device, an electromagnetic based heating
device, a light based heating device, an ultrasound based
heating device, and an exothermic chemical reaction based
heating device. The cooling device can be adapted to provide
a cooling stimulus to a palmar and/or to a plantar region
and/or to an area of glabrous skin on the face of the subject.
Optionally, the cooling device comprises a liquid that is
cooled to a temperature lowerthan the glabroustissue.
Also provided are systems for warming the core body
temperature of a subject. The systems include a heating
device configured to apply heat to peripheral thermoregula-
tory control tissue ofthe subject. The applied heatincreases or
maintains perfusion ofblood in the glabroustissue. The sys-
tems further comprise a warming device configured to apply
a warmingstimulusto the glabrous tissue and may optionally
comprise a device adapted to apply negative pressure to the
glabroustissue.
The heating device can be adapted to deliver heat to the
cervical spinal region and/or the lumbarspinal region of the
subject. Optionally, the heating device is configured to heat
the skin overlying the peripheral thermoregulatory control
tissue ofthe subject. Optionally, the heating device is config-
ured to heatthe tissue below the skin overlying the peripheral
thermoregulatory control tissue of the subject. The heating
device canbe optionally selected from the group consisting of
a resistive heating device, an electromagnetic based heating
device, a light based heating device, an ultrasound based
heating device, and an exothermic chemical reaction based
heating device. The warming device can be adapted to pro-
vide a warming stimulus to a palmarand/orto a plantar region
and/or to an area of glabrous skin on the face of the subject.
Optionally, the warming device can be selected from the
group consisting ofa resistive heating device, an electromag-
US 8,617,230 B2
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netic based heating device, a light based heating device, an
ultrasound based heating device, and an exothermic chemical
reaction based heating device.
These and other features and advantages of the present
invention will become morereadily apparent to those skilled
in the art upon consideration of the following detailed
description and accompanying drawings, which describe
both the preferred and alternative embodimentsofthe present
invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG.1 is a schematic illustration of an example system for
altering temperature in a mammalian body.
FIG. 2A is a schematic illustration of an example system
for altering temperature in a mammalian body.
FIG. 2B is a schematic cross sectional illustration of the
cooling device 301 of FIG. 2A taken across the line 2B-2B.
FIG. 3A is a schematic illustration ofheat application to the
cervical spinal thermoregulatory tissue of a subject.
FIG. 3B is a schematic illustration of a device for heat
applicationto the cervical spinal thermoregulatory tissue of a
subject.
FIG. 4 is a schematic illustration showing aspects of an
example system for cooling or heating the core temperature of
a mammalian subject.
FIG. 5 is a flow diagram showing example methods for
altering temperature in a mammalian subject.
FIGS. 6A and 6B are schematic illustrations showing
aspects of the example system of FIG.4.
FIG.7 is a schematicillustration of aspects of a system for
altering temperature in a mammalian body.
FIG. 8 is a schematicillustration of aspects of a system for
altering temperature in a mammalian body.
FIG. 9 is a schematicillustration of aspects of a system for
altering temperature in a mammalian body.
FIG. 10 is a schematic illustration ofaspects ofa system for
altering temperature in a mammalian body.
FIG. 11 is a schematic illustration ofaspects ofa system for
altering temperature in a mammalian body.
FIG. 12 is a schematic illustration ofaspects ofa system for
altering temperature in a mammalian body.
FIG. 13 is a schematic illustration ofaspects ofa system for
altering temperature in a mammalian body.
FIG. 14 is a schematic illustration ofaspects ofa system for
altering temperature in a mammalian body.
FIG. 15 is a graph showing the effect of application of
negative pressure on blood perfusion in a hand.
FIG.16 is a graph showing the temperature of a hand over
time.
FIG. 17 is a graph showingincrease in blood perfusion in a
handas a function of applied negative pressure.
FIG. 18 is a graph showing thermal flux, pressure and
temperature over time.
FIG. 19 illustrates graphs showing increaseinbloodflow to
palmararteriovenous anastomoses (AVAs) by cervical heat-
ing and temperature of the neck of a subject.
FIG. 20 illustrates graphs showing increaseinbloodflow to
plantar arteriovenous anastomoses (AVAs) by cervical heat-
ing and temperature of the neck of a subject.
FIG. 211s a graphillustrating temperature ofspine skin and
temperature of a hand overtime.
FIG. 221s a graphillustrating temperature ofspine skin and
plantar temperature over time.
FIG. 23 illustrates graphs showing warming of glabrous
skin via increased blood flow through glabroustissues of the
hand and blood perfusion of glabrous skin over time.
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FIG.24illustrates graphs showing core cooling via cervi-
cal heating in conjunction with palmarand plantar cooling,
the temperature of the neck over time and the temperature of
the palm over time.
Like reference numbers and designations in the various
drawings indicate like elements.
DETAILED DESCRIPTION
The present invention now will be described more fully
hereinafter with reference to specific embodiments of the
invention. Indeed, the invention can be embodied in many
different forms and should not be construedas limited to the
embodiments set forth herein; rather, these embodiments are
provided so that this disclosure will satisfy applicable legal
requirements.
Mammalian body temperature is tightly regulated by an
internal autonomic regulatory system which comprises cen-
tral controllers and the blood circulatory system, plus mecha-
nisms for adjusting the rate and locations of internal energy
generation. The circulatory system covers the entire body and
delivers heat from the bodycore to the peripheralareas,or, in
less frequent circumstances, delivers heat from the periphery
to the core.
Alteration of the blood flow through the skin plays an
important role in temperature regulation. For example, in
nonglabrous skin vasodilation (dilation of arterioles and
small arteries) and vasoconstriction (constriction ofarterioles
and small arteries) increase or decrease blood flow to match
thermoregulatory needs. Both the processes of vasoconstric-
tion and vasodilation are regulated by active means in
response to a combination of local, systemic, and central
inputs.
Normally, when body and/or environmental temperatures
are high, vasodilation favors high blood flow to the surface
areas involved with heat exchange, thus increasing heat loss
to the environmentand reduction in the deep body core region
temperature. As environmental and/or body temperatures
fall, vasoconstriction reduces blood flow to the skin surfaces
and minimizes heat loss to the environment.
One important effector of the thermoregulatory system is
controlled by bloodflow to specialized skin areas ofthe body
at non-hairy skin surfaces, also referred to as glabrous skin,
and includes skin at the palmsofthe hands,soles of the feet,
and the ears, cheeks, forehead, and nose regionsor any area of
skin that contains a special vascular structure that is effective
in affecting heat transfer between circulating blood and the
body surface. Basal to the skin in these areas are unique
anatomical vascular structures called venous plexuses. These
structures serve to deliver large volumes ofblood adjacent to
the skin surface under conditions of vasodilation. By this
delivery of blood, significant heat transfer may occurfor the
maintenance of internal organs within a functional tempera-
ture range.
Bloodis permitted to pass through the venousplexusstruc-
tures by wayof arteriovenous anastamoses (AVAs) that are
blood vessels that directly shunt arterial blood to the veins
without passing through the capillaries. When vasodilated,
the AVAs have a diameter an order of magnitude or greater
than the capillaries, thereby providing a low flow resistance
pathway for blood circulating from the heart. At full vasodi-
lation the AVAs present amongthe lowest flow resistance of
the entire circulatory system, resulting in a considerable frac-
tion of the total cardiac output flowing through them. The
relative proximity ofthe cutaneous AVAsto the surface ofthe
body, and the potential for carrying large rates ofblood flow
make the AVAsa very effective heat exchange vehicle in the
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thermoregulatory apparatus. The AVAsare an integral part of
the body’s heat transfer system, providing important ther-
moregulatory control. Regulation oftheAVA flow diameteris
unique in comparison to the cutaneous microcirculation in
nonglabrous skin. Adjustmentin the flow resistance through
AVAsis controlled by activation and relaxation of vasocon-
striction.
Thermal stimulation of the peripheral thermoregulatory
controltissue can cause an increase in the mean value ofAVA
flow wherein the vasomotivefluctuations are superimposedat
a higher average flow. Removal of the thermal stimulation of
the peripheral thermoregulatory control tissue can result in a
lowering of the mean AVA flow as the relaxing input to the
AVA vasoconstriction activity is diminished. This direct cou-
pling between thermalstimulation of peripheral thermoregu-
latory control tissue andAVA perfusionrate offers a powerful
opportunity to manipulate convective heat transfer processes
involving glabrous skin, including convective movement of
energy between the body surface andcore viathe circulation
ofblood to and from the AVAs, without involving inputs from
the thermoregulatory control tissue of the hypothalamus
The operation of this system is remarkablyefficient over a
broad spectrum of physiological states and environmental
conditions. In certain circumstances, however, the ther-
moregulatory system is unable to maintain the core tempera-
ture within the set operational range, or there may be thera-
peutic or prophylactic reasons to override the system to cause
changes in the core temperature beyond the normalrange. In
these cases, devices and methodsare applied interventionally
either to assist or to override the thermoregulatory system.
A different challenge in regulating the body core tempera-
ture arises under conditions for which the brain becomes
starved of oxygen owing to a medical event such as cardiac
arrest, stroke, or traumatic brain injury. Laboratory andclini-
cal data indicate that if the body core, and particularly the
brain, temperature can be reducedbyaslittle as 2° C. within
approximately 90 minutes of the precipitating event, a sig-
nificant therapeutic benefit is realized to limit mortality and
morbidity. Unfortunately, the function of the thermoregula-
tory system resists lowering the core temperature from a state
of normothermia via cutaneous vasoconstriction to increase
the thermal resistance between the skin and core and by
shivering to increase the rate of internal metabolic heat gen-
eration.
An example is the use oftherapeutic hypothermia to treat a
subject whois suffering an episodeofbrain ischemia that may
be causedby stroke, cardiac arrest, traumatic brain injury, or
another condition. Such a subject may bein an initial state of
AVA vasoconstriction. At this time, when therapeutic hypo-
thermia is applied within a short time window ofefficacy,
according to the methods of the disclosure, a state of AVA
vasodilatation is induced on demand.For example, using the
described methods, systems and devices therapeutic hypoth-
ermia can be induced in a subject at about 90 minutes or less
following an insult to a subject that would benefit from thera-
peutic hypothermia. For example, following an insult to the
brain, heart or other tissue, therapeutic hypothermia can be
induced at about 90 minutes or less from the insult.
Surface cooling over large areas of skin is ineffective
because it induces vasoconstriction, thereby eliminating
direct circulation ofblood between the skin and core, whichis
a much moreeffective heat transfer mechanism than parasitic
conduction through the bodystructures. Alternatively, meth-
ods have been developed for cooling the core directly by
infusion of large volumesofchilled saline solution into the
circulatory system. Collateral drawbacks associated withthis
technology include the necessity ofcanulating the circulatory
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system under sterile conditions and introduction of added
volumeof fluid into the blood which can result in elevated
blood pressure. Since this technologyis typically practiced in
a medicalfacility, precious time during the windowofthera-
peutic opportunity (approximately 90 minutes) is lost during
transport following the precipitating event to a medical facil-
ity and the initiation of therapy. The systems and methods
described herein can be used to produce a state oftherapeutic
hypothermia on demand following a brain ischemia produc-
ing event within 90 minutes.
Another thermoregulatory challenge occurs when a person
is hypothermic with a necessity of being rewarmed to nor-
motheria in the absence of conditions such as anesthesia that
would result in a state ofvasodilation in the cutaneouscircu-
lation. The mosteffective heat transport mechanism to warm
the body core is by the circulation ofblood between the skin
and the core. However, hypothermia-induced cutaneous
vasoconstriction blocks this mechanism. The systems and
methods described herein bypassthis state to gain convective
access to the body thermal core for warming.
A further need arises when a person is subjected to a cold
environmentfor a period oftime sufficient to elicit vasocon-
striction of the AVAs, particularly in the hands and feet.
Althoughthis standard thermoregulatory response is conser-
vative ofthe body’s core energy and is important for long term
survival, in the short term it creates a condition ofdiscomfort,
with a strong sensation ofhaving cold handsandfeet. Typical
responses are: to adopt behaviors to attempt to warm the
hands andfeet; to provide increased insulation surrounding
the handsandfeet; and/or to apply various devicesto actively
warm the hands and feet. However, these measures are not
generally effective in the short term since they do not address
the source of cold sensation, that being vasoconstriction of
AVAs.
The described methods and devices can be usedto trigger
the opening of vasoconstricted AVAs on demand, in the
absence of extreme local conditions that may override all
other control signals, to produce a high level ofblood perfu-
sion through glabrous skin. Vasodilation of the vasocon-
stricted, or more mechanistically, relaxation of the vasocon-
striction of AVAs, enables the resolution of all of the
foregoing thermal physiological challenges.
Referring to FIG. 1 an example system 200 isillustrated.
The system 200 can be used to heat or cool a mammal’s core
temperature. The system can also be used to heat or cool
glabroustissue of a mammal.
The system 200 includes a heating element 202, also
referred to as a heating device. The heating element 202 can
comprise any device that can be used to heat skin and/or
underlying tissues of a mammalian body. For example, the
heating element may comprise a resistive heating element and
thusactas a traditional heating pad when supplied with elec-
trical current. In this regard, the heating element 202 can
receive current from a power source 232. The heating element
202, however,is not limitedto a resistive heating device, such
as a heating pad.
The heating element 202 can be any device that can raise
the temperature of a mammal’s skin and/orthe tissues under-
lying the skin of a mammal’s body. Oneskilled in theart will
therefore appreciate that many alternative heating elements
can be used. Several other non-limiting examples include
exothermic chemical reactions, application of electromag-
netic energy, light, ultrasound or other energy to the skin/
underlying tissues. Thus, many different devices and process
maybe applied for heating the peripheral thermoregulatory
control tissue to raise its temperature to a degree wherein the
level of stimulation reaches the threshold requisite to cause
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relaxation of the vasoconstrictive effect on AVAs in glabrous
skin. Example heating devices use surface delivery ofheat to
the skin. Other example heating devices use deeptissuedeliv-
ery ofheat.
Theincrease in temperature causedby the heating element
can be measured and/or monitored by a temperature sensing
device 216. The temperature sensing device 216 can be posi-
tioned in proximity to the heating element 202 such that it can
optionally determine temperature information including, for
example, if the temperature of the skin or underlying tissues
has been increased, the extent of such increase, and any
temporal fluctuations in temperature in the skin or tissues
proximate the heating element. Optionally, temperature
information can be communicated to a temperature sensing
module 244 of a computer 224. The temperature information
can be processed, for example, using the processor 226 and
such processed information can be used to regulate the inten-
sity of heat and duration of heat produced by the heating
element. For example, the power module 232 can also be in
operative communication with the processor 226 and the
temperature information can be used to increase or decrease
the powersupply to the heating element 202.
Heat from the heating element 202 can be usedto trigger,
on demand, the relaxing of vasoconstriction ofAVAsin gla-
brous skin. There are numerous benefits of increased AVA
perfusion such as gaining access to cutaneous blood flow for
convective heat transfer of blood with heating and cooling
sources placed on the surface of the skin to provide efficient
transport of energy between the body core and the body
exterior surface via the circulation of blood. Another benefit
ofincreasedAVA perfusion from a state ofvasoconstrictionis
the addedheattransfer to the skin from warm bloodcirculat-
ing from the body core, thereby reducing or eliminating a
feeling of coldness experienced in vasoconstricted glabrous
skin of the hands and feet, which may be perceived as being
uncomfortable.
A method for causing AVAs to vasodilate is to apply a
heating sourceto tissues at a site ofthermoregulatory control
thatis peripheral to the preoptic hypothalamus. Thus, thermal
stimulation of peripheral thermoregulatory control tissue via
heating by multiple alternative means include, but are not
limited to, (a) a heat source applied to the surface ofthe skin,
(b) deep heating via an infrared source, (c) deep heating via an
electromagnetic source such as in diathermy, and (d) deep
heating via an ultrasound source. Peripheral thermoregula-
tory tissue includes tissue that when heated exerts control on
AVAsanddoes notinclude the brain and hypothalamus.
FIGS. 3A and 3B show that among peripheral areas that
can be heatedfor this purposeis that tissue ofand proximal to
the spinal cord, including the cervical and lumbar areas that
are rich in parasympathetic innervation. FIG.3A illustrates a
cross sectional view ofthe spine and overlying tissues during
heating to stimulate blood flow through the arteriovenous
anastomoses by which a heating source 202 is applied either
to the skin surface or by a penetrating mechanism to reach
deepertissues through the skin and toward the spine to pro-
duce an elevated temperature in these tissues. Heat penetra-
tion is illustrated by the wave emanating from a source such
as a heating pad throughthecrosssectionofthe cervical spine
and associated tissues.
Whenthe peripheral area heated is the cervical spinal area
the heating elementorheating source 202 canbe incorporated
into a wearable device to that can operatively apply heat to the
cervical spinal area. For example, the heating source 202 can
be incorporated into a wearable pillow. Optionally, the heat-
ing source, and portions of the pillow, can be contoured to
portions of the cervical anatomy of the subject to provide
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good thermal contact between the heating source and the skin
ofthe subject. The pillow also optionally provides overlying
thermalinsulation atthe site of heating.
Therefore, an effective strategy to control AVAsis to apply
localized heating to the skin in an area peripheral to both the
brain and to the glabrous skin containing AVAshaving para-
sympathetic thermal innervation that controls AVA vasocon-
striction. The heated area can be smallso asto limit the total
heat transfer to the body, avoiding causing a significant
increase in the total energy ofthe body and a concomitantrise
in core temperature. Areas other than the cervical and lumbar
spine can also be heated resulting in vasodilation of AVAs.
Increased blood flow through the AVAs can be readily mea-
sured using, for example, Doppler ultrasound techniques.
Thus, areas peripheral to the preoptic hypothalamus that
when heated cause increased blood flow through the AVAs
can be readily determined.
A period ofthermalstimulation on the skin surface is used
to allow sufficient time for heat to diffuse inwardly to reach a
depth at which the thermal receptors are located interior or
proximalto the spine. The stimulation signal to cause AVA
vasodilation may also depend on the magnitudeofthe spatial
temperature gradient from the surface of the skin inward
and/or on the temporal gradient causing a rise in temperature.
A stimulating signal may be a combinationofthe temperature
and temperature gradientat the stimulationsite.
The heating process is conducted in a manner wherein the
temperature of the target tissue is increased sufficiently to
cause the relaxation of vasoconstricted AVAs. The amount
and methodofheating can be sufficient to cause a rise in the
target tissueto at least 39° C. In other embodiments,to at least
40° C. In other embodiments, to at least 41° C. In other
embodiments, to at least 42° C. In other embodiments,to at
least 43° C. In all embodiments, the temperature ofthe target
tissue does not exceed a safety threshold above which ther-
mally induced injury occurs. For mosttissues, this threshold
temperature is 43° C.
Therefore, the level of thermal stimulation can be above a
threshold for causingAVA vasodilation and below a threshold
for causing thermal injury. The level of stimulation may be
within the range of temperatures of 39° C. to 43° C. for 1
minute or moreto cause vasodilation, depending ontheinitial
thermalstate of the body. For example, the level of stimula-
tion may be within the range oftemperatures of 39° C.to 43°
C. for 5 minutes or more to cause vasodilation, depending on
the initial thermal state of the body and the method and
intensity of heating.
For methodsthat involve heating the skin surface, a mini-
mal period of thermal stimulation may be required to allow
sufficient timefor heat to diffuse inwardly to reach a depth at
which the thermal receptors are located that provide inputs
that control blood flow to the AVAs. The stimulation signal to
cause AVA vasodilation may also be dependent on the mag-
nitude ofthe temperature gradient from the surface ofthe skin
inward and the time rate of change of temperature.
The heating process has a duration sufficient to cause an
initial increase in vasodilation ofAVAsto allow greater blood
flow. Optionally, the heating process is maintained until the
AVA vasodilation reaches a maximum value, which can be
measured, for example, by Doppler velocimetry.
Optionally, the heating process will be maintained for the
entire period for which increased blood flow through the
AVAsis desired. The heating process can be activated in a
time-wise oscillatory mannerinwhich the magnitude ofheat-
ing is alternatively increased and decreased. The periodicity
of the increasing and decreasing heating may have a cycle
varying from less than one second to more than ten minutes.
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Optionally, where periodicity ofheating is applied, the period
ofa single cycle can be more than one second andless than 10
minutes.
For embodiments wherein a regime of alternatively
increasing and decreasing heating is applied, the relative peri-
ods of greater and lesser or no heating may be equal or
unequal. Either the period of greater heating or the period of
lesser or no heating maybelarger ifthey are not equal. Forall
embodiments, the magnitude ofheating can be increased and
decreasedat least once, and in some embodiments, more than
one time. For all embodimentsthe rate of increase ofheating
and the rate of decrease of heating may or may notbe equal,
and both may or may not be linear. For embodiments for
whichthe heating is not constantforits duration,the rates and
time-wise patterns of increasing and decreasing magnitudes
of heating may be designed and adjusted to maximize the
simulation of the target tissue in the peripheral thermoregu-
latory control centertissue that regulates the relaxing ofvaso-
constrictedAVAs. Any desired heating protocol can be imple-
mented using the computer 224. The heating protocols can be
programmed and/or modified by input 234 from a user.
The described systems and methods can cause the AVAsto
becomevasodilated in their basestate so thatthe flow ofblood
through glabrous skin can serve as a convective heat transfer
medium.If the AVAs are vasoconstricted in a modethat has
the objective of conserving the energy of the body core, a
signal consistent with the body rejecting energy from the core
can be used to cause the AVAs to vasodilate. A primary
vaso-control signal to the AVAsoriginates in the hypothala-
musandis based on the temperature ofthat tissue. For appli-
cations with the objective of cooling the brain for medical
purposes, such as in therapeutic hypothermia, warming the
hypothalamus to cause AVA vasodilation is counter-produc-
tive.
Referring now to FIG. 5, the combined physiological and
thermodynamic mechanism of action is illustrated. For
example, as shown in 602, vasodilation can be triggered by
heating peripheral input sties of thermoregulatory control
604. The heating can relax the active vasoconstriction of
glabrous AVAs 606. The relaxing of vasoconstriction 606
leads to increased perfusion of blood in glabrous skin 608.
The increased perfusion of blood leads to increased skin
temperature in the absence of surface cooling 610. Thus, the
system 200 shownin FIG.1 can optionally be used to increase
glabrous skin temperature. In this example, additional heat-
ing or cooling of the glabrous skin is optional.
A method is therefore provided for heating the glabrous
skin of a mammalian subject comprising applying heat to an
area ofthe subject that causes vasodilation ofAVAslocated in
the glabrous tissue. This method may be desirable when
increasing the temperature of glabrousskin is desirable, such
as, for example, when the subject’s hands, feet or face is cold.
To implement this method, a system can be used that com-
prises a heating element applied to an area ofthe subject that
causes vasodilation of AVAs located in the glabroustissue.
For example, such a system can include a heating element
configured for heating the skin ortissues ofthe cervical spinal
or lumbar spinal region.
In other examples, the described systems can be used to
heat or cool a subject’s core temperature. Referring again to
FIG.1, the system 200 can comprise a glabrous skin cooler or
heater device 204. For cooling operation, the device 204 can
receive chilled or cooledfluid or gas trough a conduit 208. A
pump 210 can actively pump the cooled fluid or gas into and
through the device 204. The movementofcooled fluid or gas
through the device cools the device. A refrigeration device
206, such as a thermoelectric refrigerator, can be used to cool
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the fluid or gas that is circulated through the device 204 and
conduit 208. The pump 210 and refrigeration device can both
be in operative communication with the computer 224 such
that the temperature ofthe device and cooling protocol ofthe
device can be controlled by the computer and through user
input 234. Ifheating ofthe glabrousskin is desired the device
204 can provide heating as an alternative to cooling. The
device can apply heat to the glabrous skin and underlying
tissues using any of the mechanismsdescribed abovein rela-
tion the heating element 202.
In addition, the system can comprise a temperature sensor
220 positioned to detect the temperature of the device 204 or
to detect the temperature of the glabrous skin in proximity to
the device 204. This temperature information can be commu-
nicated to the computer 224 where it can be processed to
determine desired cooling or heating characteristics of the
device 204 on the glabrous skin.
Optionally, the system 200 further comprises a vacuum
214. The vacuum 214is in operative communication with the
device 204 by wayofthe vacuum line 212. The vacuum can be
used to exert negative pressure on the glabrous skin on which
the device 204 is cooling or heating. The negative pressure
can be used to enhancethe dilatation ofAVAs in the subject’s
glabrous skin. As shown in the system 200, the vacuum and
therefore the negative pressure exerted on the glabrous skin
can be controlled by the computer 224. Specifically, the
vacuum is in operative communicationwith the computer 224
by way of a vacuum module 242.In addition, the device 204
can be equippedwith a pressure sensor 222thatis in operative
communication with the computer 224 by wayof a pressure
sensing module 240. In this way, the computer 224 may
process pressure information and temperature information
and this information may be used to adjust factors affecting
the operation of the device 204 such as the temperature or
temporal characteristics of the cooling fluid or gas circulated
through the device 204 or the negative pressure or temporal
characteristics thereof.
The system 200, when used with the cooling or heating
device 204 can be used to alter the core temperature of a
subject’s body. In this regard, a temperature sensor 218 can by
optionally positioned to take or to monitor the central tem-
perature of the subject. The temperature sensor 218 can be
positioned in suitable way for obtaining one or more central
temperature reading from a subject. For example, the tem-
perature sensor can be optionally placed in the subject’s ear
canal, oral cavity or rectum. The temperature sensor can also
be optionally paced on the forehead or axillary region of a
subject.
Withoutlimiting any specific embodimentto any particular
mechanism ofaction, vasodilating and/or enlarging AVAs by
heating using the heating element 202 causes diversion of a
large fraction of cardiac outputto the skin. The skin mediates
heat exchange between blood flowing through the AVAs and
the environment, which heat may then be convected via the
circulation of bloodto (for heating) or from (for cooling) the
body thermalcore.
The enhanced flow of blood through vasodilated AVAs
therefore provides an opportunity to cause an increased flow
of energy between the body surface and body core by apply-
ing heating or cooling to the glabrous skin surface, thereby
heating or cooling blood perfused through the AVAsthat will
then circulate back to the core at a temperature that will
induce heating or cooling ofthe core tissues.
Referring again to FIG. 5, a subject’s core temperature can
optionally be cooled 612. The steps of cooling the subject’s
core temperature include cooling the glabrous skin 614. Such
cooling can be accomplished as described above using the
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device 204. Cooling ofthe glabrous skin 614 causes diffusion
of heat from deep skin structures to the surface 616. In addi-
tion, the method can comprise increasing the perfusion of
blood in the glabrous skin as shownin steps 602-608.
The combinationofthe increased perfusion ofblood in the
glabrous skin 608 and diffusion ofheat from deep skin struc-
tures to the surface 616 results in convective cooling ofblood
flowing through AVAsin the glabrous skin 618. The cooled
bloodis circulated from the peripheral AVAsto the body core
with minimal heat exchange 620. This results in convective
warming of the blood in the body core to lower the core
temperature 622. A peripheral thermal stimulation may be
required to be maintained past the initial time at which
vasodilation starts, up to the entire period during whichcool-
ing maybe applied to glabrous skin with vasodilatedAVAsto
produce a progressively increasing state oftherapeutic hypo-
thermia. Optionally, surface cooling is provided to an area of
glabrous skin and simultaneous warming to a small area of
skin rich in thermal parasympathetic innervations that con-
trols AVA blood flow.
In the described systems and methods, cooling may be
produced by the application of one or more pre-chilled gel
packs having a massandinitial temperature sized to produce
a desired drop in body thermal core temperature,or, alterna-
tively, warming may be produced by application of one or
more pre-warmedgel packs to produce a required increase in
body thermal core temperature. The pre-chilled and pre-
warmed gel packs may be reusable or disposable following
use.
Cooling may optionally be produced by the mixing of
chemical elements contained within a flexible package that
undergo an endothermic process when mixed thereby reduc-
ing the temperature of the mixture. The mixture components
may be prepackagedin a single packwith interiorbarriers that
separate the chemical components until the time when the
cooling is to be produced, whereupon the barriers may be
ruptured to enable the mixing of components with an endot-
hermic effect.
Also referring to FIG. 5, a subject’s core temperature can
optionally be heated 624. The steps of heating the subject’s
core temperature include heating the glabrous skin 626. Such
heating can be accomplished as described above using the
device 204. Heating ofthe glabrous skin 626 causes diffusion
ofheat away from the skin surface and towards the deep skin
structures 628. In addition, the method can comprise increas-
ing the perfusion of blood in the glabrous skin as shown in
steps 602-608. The combinationofthe increased perfusion of
bloodin the glabrous skin 608 and diffusion of heat towards
the deep skin structures results in convective warming of
blood flowing through AVAsin the glabrous skin 630. The
warmed bloodis circulated from the peripheral AVAs to the
body core with minimal heat exchange 632. This results in
convective cooling of the blood in the body core to raise the
core temperature 634. Optionally, surface warming is pro-
vided to an area of glabrous skin and simultaneous warming
to a small area of skin rich in thermal parasympathetic inner-
vations that controls AVA blood flow.
Warming may be produced by mixing chemical elements
that undergo an exothermic process causing the temperature
ofthe mixtureto rise. In some embodiments, warming may be
generated by exposing a sealed package of chemicals to oxy-
gen or air by rupturing an impermeable sealing cover result-
ing in a sustained increase in temperature of the pack. The
chemical mixing packs that operate by rupturing a membrane
or barrier or cover are disposable after a single use.
Pre-chilled and pre-warmed gel packs and endothermic
and exothermic chemical mixing packs may all be flexible
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allowing for conformation of the pack to the shape of the
glabrous skin surface, thereby ensuring better thermal contact
than if the cooling or warming substrate is rigid.
In some embodimentsthe chilled or warmed packs may be
located peripherally to the glabrous skin where they cool or
warm a liquid that is circulated under the action of a pump to
a flexible bladder positioned in contact with glabrous skin.
In some embodiments, a warming or cooling pack applied
to glabrous skin may be equipped with one or more attach-
ment straps to aid in maintaining effective thermal contact
between the pack and glabrous skin. These embodiments may
be particularly useful under conditions in which a subjectis
unable to actively participate in ensuring that a best level of
heat transfer occurs between the pack and skin, such as when
the subject is not aware of the treatment process or is uncon-
scious.
Referring now to FIGS. 2A and 2B, an example system 300
is shown for cooling core body temperature. As described
with relation to FIG. 1, the example system comprises a
computer 224 and a heating element 202. The heating ele-
ment can be used to heat subjecttissue to lead to dilation of
AVAsin the subject’s glabrous skin. A temperature sensor
216, also described, above can detect the temperature of the
skin and/or tissue in proximity to the heating element 202. As
the temperature sensor 216 is in operative communication
with the computer 224 temperature readings from the tem-
perature sensor can be used to provide a desired level of
heating from the heating element 202.
The system 300 further comprises a heat exchanger in
communication with the conduit 208 comprising the cooling
fluid or gas. The heat exchanger can comprise a compressor
306 and a source ofrefrigerant 302, such as R12. The heat
exchanger can further comprise a temperature sensor 308 to
sense the temperature of refrigerant prior to the conduit 208
and a second temperature sensor 310 subsequentto the con-
duit. Refrigerant can be circulated through the tube 304 to
cool fluid in the conduit 208.
The conduit 208 can hold cooled fluid or gas that can be
pumpedinto and through a cooling sleeve 301. The cooling
sleeve 301 can be optionally placed over the glabrous skin of
the hand, foot, or face. FIG. 2B showsa cross section of the
sleeve across the line 2B-2B. Two additional temperature
sensors can be positioned to monitor the temperature of the
fluid or gas in the conduit. A first temperature sensor 314 can
detect/monitor the temperature of fluid or gas entering the
sleeve. A second temperature sensor 312 can detect/monitor
the temperature of fluid or gas leaving the sleeve.
Each temperature sensor 308, 310, 312 and 314 maybe in
operative communication with the computer 224 through a
temperature sensor module 244.In addition, the compressor
306 and the pump 308 are also in operative communication
with the computer 224 through a compressor 316 and pump
240 module respectively. Information collected from the tem-
perature sensors and the flux through the heat exchanger can
be used to coolthe fluid or gas in the conduit 208, and thus the
sleeve 301 to a desired temperature.
As shown in the systems 200 and 300, the methods
described herein can be implemented via a general-purpose
computing device in the form of a computer 224. The com-
ponents of the computer 224 can include, but are not limited
to, one or more processors or processing units 226, a system
memory 228, and a system bus that couples various system
components including the processor 226 to the system
memory 228.
The system bus may represent one or more of several
possible types of bus structures, including a memory bus or
memory controller, a peripheral bus, an accelerated graphics
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port, and a processoror local bus using any ofa variety ofbus
architectures. By way of example, such architectures can
include an Industry StandardArchitecture (ISA) bus, a Micro
Channel Architecture (MCA) bus, an Enhanced ISA (EISA)
bus, a Video Electronics Standards Association (VESA)local
bus, and a Peripheral Component Interconnects (PCI) bus
also known as a Mezzaninebus. The bus, andall buses speci-
fied in this description, can also be implemented over a wired
or wireless network connection and each of the subsystems,
including the processor 226, a mass storage device 230, an
operating system, application software, data, a network
adapter, system memory, an Input/Output Interface, a display
adapter, a display device, and a human machineinterface, can
be contained within one or more remote computing devices at
physically separate locations, connectedthrough busesofthis
form,in effect implementing a fully distributed system.
The computer 224 typically includesa variety ofcomputer
readable media. Such media can be any available media that
is accessible by the computer 224 and includes both volatile
and non-volatile media, removable and non-removable
media. The system memory 228 includes computer readable
mediain the form ofvolatile memory, such as random access
memory (RAM), and/or non-volatile memory, such as read
only memory (ROM). The system memory 228 typically
contains data such as data and/or program modules such as
operating system and application software that are immedi-
ately accessible to and/or are presently operated on by the
processing unit 226. The computer 226 may also include
other removable/non-removable, volatile/non-volatile com-
puter storage media. A massstorage device 230 can be a hard
disk, a removable magnetic disk, a removable optical disk,
magnetic cassettes or other magnetic storage devices, flash
memory cards, CD-ROM,digital versatile disks (DVD) or
other optical storage, random access memories (RAM), read
only memories (ROM),electrically erasable programmable
read-only memory (EEPROM), andthelike.
Any numberofprogram modules can be stored on the mass
storage device 230, including by way of example, an operat-
ing system and application software. Each of the operating
system and application software (or some combination
thereof) may include elements of the programming and the
application software. Data can also be stored on the mass
storage device. Data can be stored in any of one or more
databases known in the art. Examples of such databases
include, DB2®, Microsoft® Access, Microsoft® SQL
Server, Oracle®, mySQL, PostgreSQL, and the like. The
databases can be centralized or distributed across multiple
systems.
A user can enter commandsand information into the com-
puter 224 via an input device. Examplesofsuch input devices
include, but are not limited to, a keyboard, pointing device
(e.g., a “mouse”), a microphone,a joystick, a serial port, a
scanner, and the like. These and other input devices can be
connected to the processing unit 226 via a human machine
interface that is coupled to the system bus, but may be con-
nected by other interface and busstructures, such as a parallel
port, gameport, or a universal serial bus (USB).
The computer 224 can operate in a networked environment
using logical connections to one or more remote computing
devices. By way of example, a remote computing device can
bea personal computer, portable computer, a server, a router,
a network computer, a peer device or other common network
node, and so on. Logical connections between the computer
223 and a remote computing device can be madevia a local
area network (LAN)and a general wide area network (WAN).
Such network connections can be through a network adapter.
A network adapter can be implemented in both wired and
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wireless environments. Such networking environments are
commonplacein offices, enterprise-wide computer networks,
intranets, and the Internet.
An implementation of application software may be stored
on or transmitted across some form of computer readable
media. Computer readable media can be any available media
that can be accessed by a computer. By way of example, and
notlimitation, computer readable media may comprise “com-
puter storage media” and “communications media.” “Com-
puter storage media” include volatile and non-volatile,
removable and non-removable media implemented in any
method or technology for storage of information such as
computer readable instructions, data structures, program
modules, or other data.
Computer storage media includes, but is not limited to,
RAM, ROM, EEPROM,flash memory or other memory tech-
nology, CD-ROM,digital versatile disks (DVD)or otheropti-
cal storage, magnetic cassettes, magnetic tape, magnetic disk
storage or other magnetic storage devices, or any other
medium which can be usedto store the desired information
and which canbe accessedby a computer. An implementation
of the disclosed method may be stored on or transmitted
across some form of computer readable media.
The processing of the disclosed method can be performed
by software components. The disclosed method may be
described in the general context of computer-executable
instructions, such as program modules, being executedby one
ormore computersor other devices. Generally, program mod-
ules include computer code, routines, programs, objects,
components,data structures,etc. that perform particular tasks
or implement particular abstract data types. The disclosed
method mayalso be practiced in grid-based and distributed
computing environments where tasks are performed by
remote processing devices that are linked through a commu-
nications network. In a distributed computing environment,
program modules may be located in both local and remote
computer storage media including memory storage devices.
Although, the embodiments described abovein relation to
the system 200 and 300 can be used to cool or heat core
temperature in accordance with aspects of the invention, it
should be noted that features of these systems, including the
computer 224, are optional. For example, a system for cool-
ing core body temperature can include a heating element for
heating skin or tissue of a subject that results in dilation of
AVAsin glabrous skin. The system can further comprise a
cooling device that provides a cooling stimulus to glabrous
skin of a subject. Such a cooling device is optionally a cooled
containerof fluid, a cooled gel pack, an ice cube, or a cooled
source of gas. Similarly, a device used to heat core tempera-
ture can comprise a heating elementfor heating skin or tissue
of a subject that results in dilation ofAVAs in glabrous skin.
The system for heating can further comprise a heating device
for providing a heating stimulus to glabrous skin of a subject.
Referring now to FIG. 4 an example system is illustrated in
which a controlleris applied to coordinate the magnitudes of
spine heating (Ts) and palmar (Th) heating or cooling and
plantar (Tf) heating or cooling as functions of temperature
inputs for the core (Tc), spine (Ts) and palmar (Th) and
plantar (Tf) skin surfaces. A controller algorithm provides
safety to the user and optimum thermal performance for
applications in which the core temperature ofthe user is being
manipulated.
FIGS. 6A and B show example devices 404 and 406 for
cooling or heating the palmarorplantar glabrous skin respec-
tively. Such example devices can optionally used in the sys-
tem 200 and 300 as system element 204. Optionally, 404 and
406 are used for cooling and a conduit 208 directs flow of
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cooled fluid or gas through the devices to provide a cooling
stimulus to the palmar or plantar glabrous skin.
FIG. 6A illustrates methods and devices for heating or
cooling the surface ofglabrous palmarskin and ventral aspect
ofthe fingers of the hand that contain arteriovenous anasto-
mosis vascular structures can include establishing a contact
area with a flexible hot or cold source bladderat a specified
temperature through which flows a controlled temperature
fluid via inlet and outlet ports thereby providing a thermal
mechanism of adding or removing energy to or from the
glabrous skin, according to a specific embodiment of the
disclosure.
FIG. 6B illustrates methods and devices for heating or
cooling the surface ofglabrous plantar skin and ventral aspect
ofthe toes ofthe foot that contain arteriovenous anastomosis
vascular structures by establishing a contract area with a
flexible hot or cold source bladderat a specified temperature
through which flows a controlled temperature fluid via inlet
and outlet ports thereby providing a thermal mechanism of
adding or removing energy to or from the glabrous skin,
according to a specific example embodimentof the disclo-
sure.
As described with regard to the systems 200 and 300,
according to some embodiments, the disclosed systems and
methods may comprise applying a negative pressure to at
least a portion of a subject’s skin. For example, negative
pressure may be applied to glabrous skin on the hands, feet
and/or face. In some embodiments, a surface vacuum system
maybe maintained at a predetermined negative pressure until
the warmingor cooling is achieved,i.e.till the body core ofa
subject reaches the desired temperature.
Optionally, a chilled or warmed pack may be located
peripherally to a vacuum chamber and glabrous skin where
they cool or warm a liquid that is circulated underthe action
ofa pumpto a flexible bladder positioned in the interior ofthe
vacuum chamberin contact with glabrous skin.
The negative pressure may optionally be up to about 25 mm
Hg, up to about 50 mm Hg,up to about 75 mm Hg,and/or up
to about 100 mm Hg.In some embodiments, the devices of
the disclosure may produce negative pressure by a portable
surface vacuum system that comprises a means for manual
evacuation, for example, by a manual bulb pumping device or
a manuallineal pumping device or a manual rotary pumping
device or a manual hinged pumping device or a bellows
pumping deviceor a self-contained battery operated vacuum
pump.
A manual vacuum generating system may be operated by
application of the motion of a hand, of both hands,of a foot,
of both feet, of a combination ofhands andfeet, or by appli-
cation ofrelative motion ofother body members. The manual
vacuum generating system may be operated by a single per-
son or by the cooperation of multiple people.
A portable surface vacuum system comprises a vacuum
pumpthat maybe operably attached to an impermeable cover
designed to cover only the glabrous skin surface which is
being cooled or heated. An impermeable cover may comprise
a suction port that is attached to a vacuum pump and aperiph-
eral seal operable to seal in vacuum generated by the vacuum
pumponto a glabrousskin surface ofthe body ofthe mammal.
A surface vacuum system may also comprise a heating or a
cooling means for delivering heat or cold to a glabrous sur-
face.
Optionally, a portable surface vacuum system is used to
apply negative pressure without insertion of a body append-
age into a non-portable and/or rigidvacuum chamber.Inthese
embodiments, the outer surface ofthe vacuum confining vol-
ume (i.e. vacuum chamber or negative pressure chamber)
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may be made with an impermeable flexible material. A cool-
ing or warming pack may be placed against glabrous skin at a
site of treatmentprior to being covered with such an imper-
meable flexible material. The impermeable flexible material
maybesealed against the glabrous skin aroundits periphery.
A port placed in the impermeableflexible material provides a
connection to a vacuum generating device so that the volume
interior to the sealed perimeter may be evacuated to desired
level of negative pressure. When a vacuum is created therein
the action of atmospheric pressure on the outer surface ofthe
impermeable flexible material translates a mechanical force
onto a heating pack or a cooling pack placed against the
glabrous skin on the interior, increasing the pressure of the
pack onto the skin, thereby reducing the thermal resistance
between the pack and the skin and producing moreeffective
heat transfer between the pack andthe skin.
In other embodiments, a portable surface vacuum system
of the disclosure allows for application of negative pressure
by insertion ofa body appendageintoa portable rigid vacuum
chamber. A rigid chamber does not substantially change its
shape when a vacuum is created onthe interior. A rigid cham-
ber incorporates a sealing element at the location where a
body appendageis inserted into the chambersothata seal is
created aroundthe perimeter ofthe appendage to support and
maintain a negative pressure on the interior of the chamber.
In some embodiments, a rigid chamber of a portable
vacuum device ofthe disclosure, may have a second opening
with a sealing cover having a size sufficient to permit inser-
tion of a cooling or warming pack and for an operator to
position said pack in contact with the body appendageofthe
treatment subject.
The sealing cover may be opened and closed easily and
quickly, and in the closed position it supports the generation
ofa negative pressure in the interior ofthe rigid chamber. The
sealing covermay be opened and closedby pivoting onhinges
or by turning screw threads or by loosening and fastening
latches. A sealing medium is placed between the mating
surfaces of the cover and the rigid chamberto block the flow
of air when a negative pressure is generated interior to the
rigid chamber. The rigid chamber may have a mechanical
vacuum gaugeinstalled to enable an operator to monitor the
state ofvacuum.
In some embodiments, the surface vacuum system may
cover about 50 mm”orless of glabrous skin. Other embodi-
ments may cover up to about 500 mm?of glabrousskin.In
some applications multiple areas of glabrous skin may be
treated simultaneously sothat the total treatment area is addi-
tive of the individual areas. The actual treatment area may
vary widely depending on the area of the body having gla-
brousskin that is selected for the process, the numberofsites,
and the overall size of the subject.
Referring now to FIGS.7-14, example devices for use with
the described systems and methods are provided. FIG. 7
illustrates a cross sectional view of a portable negative pres-
sure device comprising a warming or cooling pack 5 in con-
tact with the surface of glabrous skin 4. A flexible imperme-
able cover1 is positioned overthe application area with a seal
2 aroundthe perimeter. A negative pressure 3 interior to the
cover is formed and applied to the glabrous skin. A gauge 7
can be used to monitor the level of negative pressure, and a
source of pumping 8 (vacuum) with a connection 6 to the
interior of the impermeable cover is used to generate the
negative pressure therein. The device shownin FIG.7 can,for
example, be used as the glabrous skin cooling device 204 of
systems 200 and 300.
FIG.8 illustrates a negative pressure device including a
portable surface vacuum device having a rigid vessel 20 into
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which an appendage of a body 23 may be inserted with a
pressure seal 24 circumferentially on the skin at the point of
insertion. A warming or cooling pack 21 is positioned in
contact with the surface of glabrous skin under conditions of
negative pressure on the interior of the vessel. A source is
provided for generating a negative pressure 27 inside the
vessel 20 and connected 26to the vessel interior and a gauge
25 is used for monitoring the degree ofnegative pressure. The
device shown in FIG. 8 can, for example, be used as the
glabrous skin cooling device 204 of systems 200 and 300.
FIG. 9 illustrates a portable negative pressure device
including a rigid vessel/chamber31 into which an appendage
of a body may be inserted with a pressure seal circumferen-
tially on the skin at the point ofinsertion.A second opening 33
throughwhich a warmingorcooling pack maybe inserted can
be in contact with the surface of glabrous skin under condi-
tions of negative pressure on the interior of the vessel. The
second opening can be opened and closed by rotating a
removable element 32 having male screw threads 34 that
match female threads 35 on an opening in the rigid vessel. A
sealing substance such as Teflon tape 36 is optionally applied
to the screw threads to provide a seal between the second
removable element and the rigid container when the second
element is attached so as to contain the negative pressure
interior to the rigid vessel. The removable element has an
appendage 37 that can be grasped to rotate the element for
installing or removing the elementfrom the rigid vessel ofthe
portable surface vacuum chamber. The device shown in FIG.
9 can, for example, be used as the glabrous skin cooling
device 204 of systems 200 and 300.
FIG. 10 illustrates a negative pressure device including a
portable surface vacuum chamberhaving a rigid vessel 41
into which an appendage of a body may beinserted with a
pressure seal circumferentially on the skin at the point of
insertion. The device further comprises a second opening 44
through which a warming or cooling pack maybeinserted to
be in contact with the surface of glabrous skin under condi-
tions of negative pressure on the interior of the vessel. The
second opening can be opened andclosed by pivoting a sec-
ond element42 attached by one ofmore hinges 43 to a portion
of the perimeter of the opening in the rigid vessel. One or
more latches 46 mounted on a pivot 49 and matching pins 47
or other locking devices are used to secure the second element
in a sealed position against the second opening in the rigid
vessel. A sealing substance such as Teflon tape is optionally
applied to the mating surfaces 45 of the rigid vessel and/or
second element to provide a seal between the second hinged
element andthe rigid container when the second elementis
rotated to a closed position against the rigid vessel so as to
contain the negative pressure interior to the rigid vessel. A
handle 48 is provided to open and close the second element.
The device shown in FIG. 10 can, for example, be used as the
glabrous skin cooling device 204 of systems 200 and 300.
FIG.11 illustrates a negative pressure device including a
portable vacuum chamberhavinga rigid vessel 61 into which
an appendage of a body maybeinserted with a pressure seal
circumferentially on the skin at the point of insertion. The
device includes a second opening 63 through which a warm-
ing or cooling pack may beinserted to be in contact with the
surface ofglabrous skin under conditions ofnegative pressure
on the interior of the vessel. The second opening can be
opened and closed by removal a second element 62 that is
shaped to match the openingin therigid vessel. One or more
latches 65 is mounted on a pivot 66 and matching pins 67 or
other locking devices are usedto secure the second elementin
a sealed position against the second opening in the rigid
vessel. A sealing substance such as Teflon tape is optionally
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applied to the mating surfaces 64 of the rigid vessel and/or
second elementto provide a seal between the second element
and the rigid container when the second elementis positioned
to aclosed position against the rigid vessel so as to contain the
negative pressure interior to the rigid vessel. The device
shown in FIG. 11 can, for example, be used as the glabrous
skin cooling device 204 of systems 200 and 300.
FIG.12illustrates a negative pressure device vacuum gen-
erating device. The device includes an impermeable cover 91
operably attached 86 to the vacuum generating device 87 to
produce a negative pressure on the interior 88 of the imper-
meable cover. The impermeable cover is operable to cover a
glabrous skin surface 81. The impermeable coverhasa seal-
ing means83to seal a perimeter area ofthe glabrous skin. The
impermeable cover encloses a flexible cooling or warming
pack 84in its interior and positioned against glabrous skin so
that it may exchange heat with the skin. The impermeable
coveris optionally flexible so that the combinedactions ofthe
higher exterior pressure 89 and the lower interior pressure 85
when applied across the surface area 82 of the impermeable
coverresults in a mechanical force 90 applied onto the flex-
ible cooling or heating pack to force it against the glabrous
skin providing a reduced thermal contact resistance at the
interface and improvedheat transfer between the pack and the
glabrous skin. The device shown in FIG.12 can, for example,
be used as the glabrous skin cooling device 204 of systems
200 and 300.
FIG.13 illustrates a negative pressure volume containment
device 100 which maybe applied to seal a defined area of
glabrous skin and into which may be placed a cooling or
warming pack 103 to transfer heat from or to the skin. A
peripheral seal 102 is formed around the body appendage 101
containing glabrous skin.Apressure monitoring device 104 is
used to continuously measure the pressure within the negative
pressure device. The device also includes a connection 105 to
a vacuum generating source 106 which is operable in the
absence of external power sources. Operation may be by
manual means such as manual compression of a confined
volume (a bellows or a bulb or other flexible compression
device 110), a linear pumping motion 108, a rotary pumping
motion 109, or by a powered means in which a portable
self-contained energy source 107 such as a battery drives a
vacuum pump. The device shown in FIG. 13 can, for example,
be used as the glabrous skin cooling device 204 of systems
200 and 300.
FIG.14illustrates a flexible cooling or warming pack 120
that may be inserted into the interior of a negative pressure
volume as shownin the prior figures to contact and conform
to the topology of glabrous skin of a mammalwhile transfer-
ring heat to or from the skin. The pack may be broughtto a
desired treatment temperature by pre-cooling or pre-heating,
by mixing contained chemical components previously sepa-
rated by barriers that may be rupturedat the time oftreatment
to allow an endothermic or exothermic mixing process, or by
exposing contained chemical components to air causing an
exothermic reaction after the pack is removed from an ini-
tially sealed container, according to a specific example ofthe
disclosure.
Asdescribed throughout, control ofblood flow through the
arteriovenous anastomoses of the skin is critical to ther-
moregulatory function. The ability to manipulate blood flow
through the AVAs, especially from an incipient state of vaso-
constriction, holds important consequences for medical
applications that involve the modulation of core body tem-
perature and for alleviating issues of personal thermal dis-
comfort.
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Described herein are methods, processes, systems and
devices for accomplishing on demandincreases in the flow of
blood through the AVAs and thereby the ability to raise or
lowerthe body core temperature. In some embodiments,arte-
riovenous anastomoses (AVAs), may be dilated and/or dis-
tended. Without limiting any specific embodiment to any
particular mechanism of action, dilating and/or distending
AVAs may cause diversion of a large fraction of cardiac
output to the skin. The skin may mediate heat exchange with
the environment which may then be convected to the body
thermalcore. In some embodiments, the rate ofcore tempera-
ture change maybeten timesfaster than possible using exist-
ing conventional methods and devices in the absence ofAVA
vasodilation and/or distention enhancements.
The described systems and methods can be used to cool
and/or heat the core temperature of a mammal that may or
maynotinitially be vasoconstricted. In conjunction withther-
mal stimulation of peripheral sites of thermoregulatory con-
trol to produce greater blood perfusion to glabrous skin, the
surface of glabrous skin may be heated or cooled to respec-
tively add or remove heat from blood circulating from the
body core. The disclosed methods and devices are capable of
increasing on demandthe convective flow ofheat between the
skin surface and the body core via the circulation of blood.
The methods and devices may be applied to lower the body
core temperature from a normothermic state to produce a
state ofhypothermia, and from a hyperthermic state toward a
normothermic state, and to increase the body core tempera-
ture from a hypothermic state toward a normothermicstate,
and from a normothermicstate to a hyperthermic state. An
example application of the latter process could be instances
where it is desirable to create an artificial febrile state to
enhancecancertherapies.
For some embodiments in whichtheAVAsare initially in at
least a partial state of vasoconstriction, the vasoconstriction
action ofthe AVAsis relaxed or reducedatleast in part by the
method ofheating thermal receptors in the thermoregulatory
control center peripheral to the brain so as to stimulate the
requisite input signals to reduce vasoconstriction in theAVAs.
The result of increasedAVA vasodilation is greatly decreased
flow resistance of the AVAs suchthatthere is a diversion of a
larger fraction of the cardiac output to the AVAs.
As a consequenceofthe increased blood flow through the
AVAs,the glabrous skin will be warmed bythe greater con-
vective heat transfer with blood flowing from the warmer
body core. The described systems and methods can imple-
ment various specific devices and processes for heating to
thermally stimulate peripheral thermoregulatory control tis-
sue that cause the process of warming glabrous skin via
increased convective heat exchange with warm core blood.
As a further consequence of the increased blood flow
through the AVAs, the glabrous skin can be used as a heat
transfer medium between heating or cooling sources applied
to its surface and blood flowing through the AVAs. The pro-
cess creates the opportunity to adjust the temperature of a
fraction of the cardiac output whichis circulated back to the
body core, with minimal heat exchange in the intermediate
larger diameter and higher velocity vessels, until it equili-
brates thermally with the total blood volumeandtissues ofthe
body core, thereby providing a direct transport link to exter-
nally modulate the body core temperature.
The described systems and methodscan be usedto rapidly
increase or decrease the core body temperature of a mamma-
lian body for therapeutic and other uses. For example, induc-
tion of hypothermia provides protection to the brain from
ischemic events in subjects that may have suffered impair-
ments such as cardiopulmonary arrest, ischemic stroke, sub-
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arachnoid hemorrhage, hepatic encephalopathy, perinatal
asphyxia, infantile viral encephalitis, or an acute traumatic
brain injury.
The described systems and methods may be usedto cool
the body of a user in response to a hyperthermia-inducing
activity or event. Some non-limiting examples of hyperther-
mia-inducing activities include endurance-limited activities
such as athletic performance, and/or working in an environ-
ment of high heat (mining industry, construction industry,
forestry industry, metals processing industry), and/or expo-
sure to an environment of high heat stress, and/or military
operations. The described systems and methods mayalso be
used to ameliorate or eliminate the effects ofwarming of the
body temperature to mortally dangerous temperatures higher
than the normal operating range.
The described systems and methods may be used to warm
the body of a human user in response to a hypothermia-
inducing activity or event. Some non-limiting examples of
hypothermia-inducing activities include working in
extremely cold environments, and/or extended exposureto a
very cold environment, particularly in the absence ofa sig-
nificant level of physical activity, and/or prolonged exposure
to water, and/or prolonged athletic activities in cold/water-
based environments, and/or being seated in a vehicle under
cold conditions. The described systems and methods may be
used to ameliorate or eliminate the effects of excessive cool-
ing of the body core temperature that may lead to injury
and/or death.
The described systems and methods maysafely extend the
performanceenvelopefor any ofthe foregoing typesofactivi-
ties and/or safely extend the period ofexposure to the extreme
temperature by adjusting the temperature ofthe bodycore. In
some embodiments, the user may continue to engage in the
activity or continue to be exposedto the extreme temperature
as mobility of the user is not hindered.
The described systems and methods maybeusedto induce
a state of mild hypothermia of up to 2° C. without any tech-
niquesthat are invasive to the skin surface and/or that require
sterile conditions and/orthat require accessto central electri-
cal power. In some embodiments the device or methodofthe
disclosure can be practiced by personnel with a leveloftrain-
ing commensurate with EMS medical personnel andin field
conditions without access to central electrical power.
The described systems and methods maybeusedto induce
therapeutic hypothermia for subjects or people at risk of
ischemic injury. For example, localized heating may be
applied to a peripheral site of thermoregulatory control to
cause relaxation of arteriovenous anastomosis vasoconstric-
tion to produce greater blood perfusion of glabrous skin that
can then be locally cooled to enhance convective heat transfer
in the skin to produce rapid cooling of the body thermal core
to a state of therapeutic hypothermia. This may be used to
provide treatment or neuroprotection for medical cases such
as cardiac arrest, stroke, traumatic brain injury, vasculature
surgery, neonatal brain injury and combinationsthereof.
Optionally, the systems, devices and methods can be oper-
ated or performed without external AC electrical power
sources. It may be possible to attach the system or a portion of
the systems describedto a stationary electrical power source
operating an electrically driven vacuum pump for applica-
tions in which the device is positioned within physical access
of such powersources.
Optionally, the described systems and devicesare portable.
In some embodiments, a device of the disclosure may be
light-weight. Portability and/orthe ability to operate without
an external AC electrical power source and/or light-weight
mayprovide operational functionality in some applications.
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For example, portability and/or light-weight provide an
advantage for use in an EMSvehicle, in a medicalhelicopter,
in a commercialairliner, in a military operational vehicle,at
an industrial work site, a sports playing field, and a remote
activity venue. The portability andlight-weight may make the
device desirable to carry on space craft or an aircraft to
provide immediate life saving treatment to a subject who
suffers an ischemic event. Optionally, the systems and device
maybesufficiently compactto be placed and carried in afirst
aid kit.
In some embodiments, use of a surface vacuum system to
apply negative pressure to a portion ofa glabrous skin surface
removesthe necessity of inserting an appendage comprising
glabrous skin into a rigid vacuum container.
The systems and devices of the disclosure may be com-
pletely portable and require no external AC electrical power
sources rendering them usablein critical medical care situa-
tions such at the site of an injury or road accident, or while
being carried on an ambulanceorhelicopter to provide impor-
tant rapid cooling therapy for victims ofcardiacarrest, stroke,
traumatic head injury, or neonatal brain injuries or impair-
mentto provide protection from possible ischemic injury. The
present disclosure, in some embodiments,relates to portable
heating or cooling devices, methods ofinducing flow ofblood
to the AVAs when it is initially not active, and methods to
regulate and/or adjust and/or modify the body core tempera-
ture while allowing mobility, e.g. complete mobility, for the
user.
Optionally, the surface of glabrous skin may be heated or
cooled so as to modulate the body core temperature without
adversely affecting enhancedAVA blood flow and for imple-
mentation in a wide diversity of venues and circumstances
where the medical benefits of adjusting the body core tem-
perature may be desired. Of note, the latter venues andcir-
cumstance may include producing a state of mild hypother-
mia shortly following an ischemia producing event in a
location remote from a medical care facility.
The systems or devices of can be optionally attached to a
stationary electrical power source operating an electrically
driven heat transfer fluid pump andrefrigeration system for
applications in which the deviceis positioned within physical
access of such powersources. In some embodiments, a device
of the disclosure may beportable.
The present disclosure provides methods and devices that
can elicit blood perfusion to the AVAs in glabrous skin via
focal thermal stimulation to key sites of peripheral ther-
moregulatory control. Thermalstimulationto sites ofperiph-
eral thermoregulatory control having parasympathetic inner-
vation sends signals to AVAs in glabrous skin that cause
vasoconstriction to relax, producing increased blood flow to
glabrous skin. One outcomeofthis stimulation is that in the
absenceof local heating or cooling, the glabrous skin will be
warmed from the former state of vasoconstriction. This out-
come can be usedto benefit in instances wherein warming of
the hands and/or feet will cause an increase in the state of
thermal comfort.
One application of this process is to incorporate the ther-
mal stimulation into the upper seat back of a vehicle whereby
the cervical spine can be heated in order to enhance the
comfort of occupants when the environmental temperature is
low enough to cause discomfort. Additional applications
include maintaining warmth ofthe palmar and plantar skin for
situations in which is a person is exposed to a cold environ-
ment in combination with a low level ofphysical activity over
an extended period of time, such watching an athletic event,
waiting in a hunting blind, recording observations of the
heavens, and innumerable othersituations. The invention can
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be used ina residential setting for any conditions in which the
hands and feet become uncomfortably cold and during any
time of day or night. Medical applications may include the
warming of patients who are uncomfortably cold. It may be
combined with warming of the glabrous skin surfaces to add
heat to blood circulated through the AVAsso as to circulate
heat to the body core to warm it from a state of hypothermia
as may be required.
Thermal stimulation may be induced by various means,
including direct contact of the skin with a heated surface,
directing a flow ofwarm air onto the stimulation site, and/or
applying surface and/or penetrating electromagnetic energy
at controlled wavelengths and intensity. Different means of
thermal stimulation can alter the process time to diminish
vasoconstriction ofAVAsin order to match requirements for
achieving comfort or medical benefit. The intensity of ther-
mal stimulation may be regulated via a feedback control loop
in orderto ensure safety against causing thermal injury during
stimulation and to provide optimal control ofAVA vasodila-
tion.
The physiological mechanisms that govern heat transfer
between glabrous skin and the body core via convective blood
flow through the AVAs as enhanced by application of spinal
heating to relax vasoconstriction ofAVAs andby application
of negative pressure to glabrous skin to distend AVAs were
evaluated.
EXAMPLE1
The application of negative pressure to glabrous skin was
used to cause a significant increase in the flow of blood
through the AVA vascular structure and the associated retia
venosa. A laser Doppler flow probe was used to measure the
change in blood flow in glabrous skin as a function of the
magnitude of applied negative pressure.
A human hand was placed into a sealed rigid vacuum
chamber on which was mounted an electronic negative pres-
sure gauge. An optical laser Doppler flow probe was mounted
onto the skin of the most distal pad of the middle finger to
monitor blood flow continuously. The finger was exposed to
ambient temperature air with no active cooling or warming
appliedto the skin. Control measurements were made with no
negative pressure applied following an initial acclimatization
period. The negative pressure was increased to a predeter-
mined level and held for 15 minutes, then returned to zero.
Data from a sample protocol at a negative pressure of
approximately 40 mm Hg is shown in FIG. 15. FIG. 15
depicts a blood flow plot andillustrates transient variation
that is typical of AVA vasoactivity as the lumen diameter
changes with time and thereby alters both flow impedance
and velocity. Several features regarding the mechanistic basis
of this physiological phenomenonare reflected in the data.
For example, firstly underthe action of negative pressure the
average blood perfusion rate increases by approximately
30%, which is important for negative pressure technology
function. Secondly,there is a sharp transient vasoconstriction
ofthe AVAsin conjunction with major changesin the applied
negative pressure, regardless of whether the change in pres-
sure is positive or negative. This sympathetic driven behavior
is a typical response to a sudden environmental input to the
body. Third, after the negative pressure is removed the perfu-
sion rate returns to approximately the level prior to the appli-
cation of negative pressure. This behavior points to a direct
cause and effect relationship between the increase in perfu-
sion and applied negative pressure. Fourth, there is a large
increase in perfusion by a factor of approximately three dur-
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ing the initial acclimatization period from an initial native
state ofAVA vasoconstriction.
The laser Doppler probe wasalso used to measure the skin
surface temperatureatthe site ofthe perfusion measurement.
FIG.16 illustrates the temperature history during this experi-
ment. At the start ofthe experiment,initial temperature ofthe
skin was 24° C., which is indicative of a vasoconstricted state
as is confirmed by the correspondingly low value of AVA
perfusion. FIG. 15 showsa steady transition in blood flow
overthefirst 11 minutesin the absence ofnegative pressure to
avasodilated state. FIG. 16 documents a corresponding rise in
the skin temperature by approximately 8° C. to a new equi-
librium value as the increased flow of warm blood from the
body core through the AVAs caused an interior convective
source that translated to the progressive warming of the skin
surface. This data showsthe coupling betweenAVA perfusion
level and skin heat transfer and temperature.
FIG.15 further showsthe application of negative pressure
at 11 minutes with a commensurate increase in AVA perfu-
sion. A higher perfusion rate translates into a greater convec-
tion effect between warm bloodandthe skin tissue, issuing in
a further increment in surface temperature. FIG. 16 docu-
ments the further incrementin surface temperature by 2° C.as
a result of the application of negative pressure. The net
increase in surface temperature of the skin was 10° C. as a
result of the increase in AVA perfusion. The two steps of
temperature increments correspondto the twostepsin perfu-
sion increment, demonstrating mechanistic coupling of the
two phenomena. The mechanistic action of blood perfusion
on convective heat transfer in the glabrous skin is verified by
these data.
EXAMPLE2
A series of tests, similar to those described above and
shown in FIG. 15, were conducted,eachat a different value of
negative pressure. The objective was to determine whether
there is a proportionalrelationship between the magnitude of
increase in perfusion and the magnitudeofthe applied nega-
tive pressure. Results ofthese experiments are shown in FIG.
17 whichillustrates increments in blood perfusion measured
by laser Doppler velocimetry on the most distal pad of the
middle finger when exposed to various (graded) negative
pressure values at room temperature air.
These data document a clear proportional relationship
between applied negative pressure and the resulting increase
in AVA perfusion. The mechanistic action of negative pres-
sure on blood perfusion in the subject technologyis verified
by these data.
EXAMPLE3
The palm surface of the hand was subjected to cooling by
contacting it with a flexible bladder through which chilled
water was circulated at the same time that negative pressure
wasappliedinteriorto a rigid chamber. A heat flux gauge and
thermocouple were affixed to the palm in an area where it
contacted the bladder. The protocol consisted ofan equilibra-
tion period at room temperature, followed sequentially by the
application of negative pressure, then bladder perfusion with
water at 17° C., then cessation of negative pressure, reestab-
lishment of negative pressure, and a final cessation of nega-
tive pressure.
FIG. 18 shows data from this experiment in which water
having a temperature of 23° C. was circulated through a
bladder in contact with the palm of the hand. A significant
enhancementin skin heat flux occurred (most upperlines of
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FIG. 18) when negative pressure (most lower lines ofFIG. 18)
was applied, which diminished when the negative pressure
was removed. The temperature of the skin at the site of heat
flux measurement is shownastheleast variantplot.
After an eleven (11) minute equilibration period, negative
pressure was increased to 40 mmHg (which held the heat flux
constant), and at 21 minutes water circulation through the
bladder at 17° C. was initiated with a commensurate increase
in heat flux. At 30 minutes the negative pressure wasset to
zero causing an immediate drop in heat flux. At 36 minutes
the negative pressure was reestablished to 40 mm Hg, and the
heat flux immediately jumped back to and held at the maxi-
mum value. At 41 minutes the negative pressure was again
removed, with the heatflux also falling to the previous lower
value. This data demonstrates the mechanistic coupling
between negative pressure and the enhancementofheat flow
through the skin. This coupling appears to be driven by
increased convection with blood flow through the negative
pressure distendedAVAs. The mechanistic action of negative
pressure on heattransfer in the skin for the subject technology
is verified by these data.
EXAMPLE 4
Heating skin in a peripheral area rich in parasympathetic
thermal sensors that effect AVA blood flow produces this
result. The results are shown in FIG. 21. Heating the cervical
spine of a subject was used to open vasoconstricted AVAs in
glabrous skin of the hand ofthe subject which causeda large
increase in blood perfusion, thereby warming the skin sur-
face.
FIG. 21 shows example data for a test in which a strongly
vasoconstricted state was relaxed by application offocal heat-
ing to a selected area along the spine. The total surface area
heated was quite small to avoid a total heat load that could
affect the core temperature. Core temperature was monitored
continuously and remained constant through the process. A
surface thermocouple was mounted on the palm of one hand
whenthe subject was in a state of strong vasoconstriction that
had existed for more than one hourprior to the experiment. A
thermocouple was also mounted onthe skin abovethe spine at
the site where heating was applied.
The data show thetrigger temperaturefor this effect is ina
narrow range of above about 40° C. The temperature was
restricted to below about 44° C. whichis near the threshold
for causing thermal injury. Thus, the temperature range was
from about 40° C. to below about 44° C.
Application of heat to the skin of the cervical spine leads
directly to AVA vasodilation in glabrous skin. The vasodila-
tion produced enhanced perfusion of warm blood from the
body core, convective heat transfer to the surroundingtissue,
and warming of the surface of the skin as the heat diffuses
away from the AVA vascular bed. The mechanistic action of
peripheral heating on AVA vasodilation from the vasocon-
stricted state for the subject technologyis verified by these
data.
EXAMPLE5
Warming the Cervical Spine Increases Blood Flow in
Vasoconstricted AVAs
The application of thermal stimulation via heating to spe-
cific peripheral areas of central thermoregulatory control
cause a significant increase in the flow of blood through the
AVA vascular structure and the associated retia venosa. A
fiber optic laser Doppler flow probe was used to measure the
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change in blood flow in glabrous skin as a function of the
magnitude of applied surface heating to the cervical spine. A
surface filament thermocouple was used to measure the tem-
perature of the skin on the surface at the cervical spine over
which an electric heating pad was applied.
FIGS.19 and 20 show the increase in flow ofblood through
the finger tip and secondtoe, respectively, in response to the
application ofheating on the skin surface at the cervical spine.
The data show in both areas of glabrous skin a direct incre-
mentin perfusion following elevation ofthe skin temperature
at the cervical spine.
EXAMPLE6
Warming the Cervical Spine Increases the Surface
Temperature of Initially Vasoconstricted Palmar and
Plantar Skin
Heating skin in a peripheral area rich in parasympathetic
thermal sensors produces an elevation in the temperature of
glabrous skin whenthere is an initial state of vasoconstric-
tion. Heating the cervical spine of a subject was used to open
vasoconstricted AVAsin glabrous skin ofthe hand andfoot of
the subject which causeda large increase in bloodperfusion,
thereby warming the skin surface.
FIGS.21 and 22 show example data for tests in which a
strongly vasoconstricted state was relaxed by application of
focal heating to a selected area along the spine. The total
surface area heated was quite small to avoid a total heat load
that could affect the core temperature. Core temperature was
monitored continuously and remained constant through the
process. A surface thermocouple was mounted on the palm of
one hand, FIG. 21,orto the sole ofone foot, FIG. 22, when the
subject was in a state of strong vasoconstriction that had
existed for more than one hour prior to the experiment. A
thermocouple was also mounted onthe skin abovethe spine at
the site where heating was applied.
The data show the trigger temperature forthis effect is in a
narrow range of above about 39° C. on the surface. The
temperature wasrestricted to below about 43° C., which is
near the threshold for causing thermal injury. The effective
temperature range for heating the skin surface over the cer-
vical spine to triggerAVA vasodilation ranges from about 39°
C. to below about 43° C.
Application of heat to the skin of the cervical spine leads
directly to AVA vasodilation in glabrous skin. The vasodila-
tion produced enhanced perfusion of warm blood from the
body core, convective heat transfer to the surroundingtissue,
and warming of the surface of the skin as the heat diffuses
away from the AVA vascular bed. The mechanistic action of
peripheral heating on AVA vasodilation from the vasocon-
stricted state for the subject technology is verified by these
data.
A fiber optic thermal probe was also used to measure the
skin surface temperatureat the site ofperfusion measurement
at the finger tip. FIG. 23 illustrates the temperature history
during this experiment. Initial temperature ofthe skinwas 24°
C., which is indicative of a vasoconstricted state as is con-
firmed by the correspondingly low value ofAVA perfusion.
The data for the rate of perfusion through the AVAs showsa
steady transition over the first 11 minutes to a vasodilated
state, with a corresponding rise in the skin temperature by
approximately 8° C. to a new equilibrium value as the
increased flow ofwarm blood from the body core through the
AVAscaused an interior convective source that translated to
the progressive warmingofthe skin surface. These data show
the coupling betweenAVA perfusion level and skin heat trans-
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fer. A further stimulation of blood perfusion at 11 minutes
causes a greater convection effect between warm blood and
the skin tissue, issuing in a further increment in surface tem-
perature. FIG. 23 documents the further increment in surface
temperature by 2° C. as a result ofthe application ofnegative
pressure. The net increase in surface temperature of the skin
was 10° C.as a result of the increase in AVA perfusion. The
mechanistic action of blood perfusion on convective heat
transfer in the glabrous skin is verified by these data.
EXAMPLE 7
Warming the Cervical Spine in Conjunction with
Cooling the Palmar or Plantar Skin Surfaces Causes
a Reduction in Body Core Temperature
For applications ofthe devices, systems and methodsofthe
disclosure, from a starting state wherein the AVAs are vaso-
constricted, a state of vasodilation is effected in order to
realize the benefits of enhancement of cutaneouscirculation.
An exampleis the use of therapeutic hypothermia to treat a
subject who is suffering an episode of brain ischemiathat is
caused, for example, by stroke, cardiac arrest, or traumatic
brain injury. Such a subject may be in a state of AVA vaso-
constriction. At this time, when therapeutic hypothermia is
applied within a short time windowofefficacy, according to
the methods ofthe disclosure, a state ofAVA vasodilatation is
induced and maintained throughoutthe core cooling process.
The palmarsurface of the hand and sometimesthe plantar
surface of the foot were subjected to cooling by contacting
them with a bladder through which chilled water was circu-
lated at the same time that heating was applied to the skin
overlying the cervical spine. A heat flux gauge and thermo-
couple were affixed to the palm/sole of the foot in an area
where it contacted the bladder. The protocol consisted of an
equilibration period at room temperature, followed by blad-
der perfusion with water at 20° C.
FIG. 24 showsdata from these tests. After about the 80”
minute ofthe experiment, both neck heating and palmar cool-
ing were in effect. Subsequently, in the 30 minute period
roughly between the 80” and 110” minutes, the body core of
the subject decreased about 0.4 degrees Celsius.
As usedin the specification, and in the appendedclaims,
the singular forms “a,” “an,” “the,” include plural referents
unless the context clearly dictates otherwise.
The term “comprising” and variations thereof as used
herein are used synonymously with the term “including” and
variations thereof and are open, non-limiting terms.
Many modifications and other embodiments of the inven-
tion set forth herein will come to mindto oneskilled in the art
to which this invention pertains having the benefit of the
teachings presented in the foregoing description. Therefore, it
is to be understoodthat the invention1s not to be limited to the
specific embodiments disclosed and that modifications and
other embodiments are intended to be included within the
scope of the appended claims. Although specific terms are
employed herein, they are used in a generic and descriptive
sense only and notfor purposesoflimitation.
Whatis claimedis:
1. A method for cooling the core body temperature of a
subject, comprising: applying heat to peripheral thermoregu-
latory control tissue of the subject, wherein the applied heat
increases or maintains perfusion ofblood in glabroustissue of
the subject and applying a cooling stimulus to the glabrous
tissue thereby cooling the core body temperature, wherein the
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heat is applied to the peripheral thermoregulatory control
tissue simultaneously with application of the cooling stimu-
lus to the glabroustissue.
2. The method of claim 1, further comprising applying
negative pressure to the glabroustissue.
3. The method of claim 1, wherein the peripheral ther-
moregulatory control tissue is located in the cervical spinal
region of the subject.
4. The method of claim 1, wherein the peripheral ther-
moregulatory control tissue is located in the lumbarspinal
region of the subject.
5. The method ofclaim 1, wherein the subject has suffered
an insult selected from the group consisting of cardiopulmo-
nary arrest, ischemic stroke, subarachnoid hemorrhage,
hepatic encephalopathy, trauma, brain surgery, perinatal
asphyxia, infantile encephalitis, a hyperthermic-inducing
event and acute brain injury.
6. The method ofclaim 5, wherein the subject’s core body
temperature is cooled by about ninety minutesor less after
suffering the insult.
7. The method ofclaim 6, wherein the subject’s core body
temperature is cooled by about sixty, thirty, ten or less min-
utes after suffering the insult.
8. The method of claim 1, wherein the temperature of the
thermoregulatory control tissue is raised to between about
39° C. and 43° C.
9. The methodofclaim 8, wherein the raised temperature is
maintained forat least about one minute.
10. The method ofclaim 8, wherein the raised temperature
is maintained for between about one and five minutes.
11. The method ofclaim 8, wherein the raised temperature
is maintained forat least aboutfive minutes.
* * * * *
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